Quarterly Result11 Nov 2026, 07:21 pm
Vivo Bio Tech Declares Unaudited Q2 FY27 Results
AI Summary
Vivo Bio Tech Ltd announced its unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026. The Board of Directors approved these results in a meeting held on November 11, 2026. The company also provided a limited review report from its statutory auditors, M/s. P. Murali & Co. The financial results cover both standalone and consolidated figures for the specified periods.
Key Highlights
- Board approved unaudited standalone and consolidated financial results.
- Results are for the quarter and half-year ended September 30, 2026.
- Limited Review Report from statutory auditors is enclosed.
- Board meeting held on November 11, 2026, transacted key business.
- Financials presented for both standalone and consolidated entities.
Price Impact
More from VIVOBIOT